The analysis of the impact of CHK1 and CHK2 expression in BC progression revealed that the presence of each one of these two kinases is inversely correlated with the relapse-free survival (RFS) probability only in women carrying ERα-positive BCs. The gene discussed is ESR1; the disease is breast cancer.